Trending Now
Announcements Commercial

BioCardia Announces Litigation Financing in the Case Captioned Boston Scientific Corp., et al., v. BioCardia Inc.

SAN CARLOS, Calif., April 14, 2020 (GLOBE NEWSWIRE) — BioCardia, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported it has entered into an agreement for litigation financing which has been filed today with the Securities and Exchange Commission on Form 8-K.

BioCardia, Inc. entered into a Litigation Funding Agreement with BSLF, L.L.C., an entity owned and controlled by Andrew Blank, a member of BioCardia’s board of directors, for the purpose of funding the Company’s currently pending legal proceedings and any and all claims, actions and/or proceedings relating to, or arising from, the case captioned Boston Scientific Corp., et al., v. BioCardia Inc., Case No. 3:19-05645-VC, U.S.D.C., N. D. Cal (the “Litigation”). The Litigation relates to matters the Company raised in a letter to Ms. Surbhi Sarna, nVision Medical and Boston Scientific based on BioCardia’s discovery in January 2019 that Ms. Sarna had assigned to a company she founded, nVision Medical, a patent and patent applications she had filed while a BioCardia employee. nVision subsequently was acquired by Boston Scientific.

BioCardia made various claims, including that the patent and patent application rightfully belonged to BioCardia pursuant to Ms. Sarna’s invention assignment agreement, that the proceeds from the sale of nVision to Boston Scientific rightfully belonged to BioCardia because they were the direct result of Ms. Sarna’s breach of her obligation to assign to BioCardia the patent and patent applications and the use of misappropriated BioCardia trade secrets.  On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed Inc., and Fortis Advisors LLC (the “Boston Scientific Parties”) filed a complaint against BioCardia in the United States District Court Northern District of California, Case no. 3:19-05645-VC, seeking declarations that the claims made in BioCardia’s correspondence were without basis. On October 31, 2019, BioCardia filed a counterclaim against the Boston Scientific Parties and Ms. Sarna for breach of contract, misappropriation of trade secrets and correction of inventorship on the patents naming Ms. Sarna as an inventor. BioCardia seeks imposition of constructive trusts both on the patents naming Ms. Sarna as an inventor and the proceeds received from the sale of nVision to Boston Scientific, as well as damages, including unjust enrichment damages measured by the proceeds received from the sale of nVision to Boston Scientific.

Under the terms of the Funding Agreement, the Funder agreed to fund the legal fees and costs incurred by the Company in connection with the Litigation on and after March 1, 2020 on a non-recourse basis in return for a share of the litigation proceeds.  Details of the Funding Agreement are available in the Form 8-K filed today.

BioCardia CEO Peter Altman, PhD, said, “This litigation financing gives BioCardia the wherewithal to pursue its claims in court. This preserves our investment focus on advancing our important cell therapy product pipeline to treat cardiovascular diseases, and the commercialization of our FDA-approved enabling device products.”

About BioCardia®
BioCardia, Inc., headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular disease. CardiAMP™ and CardiALLO™ cell therapies are the Company’s biotherapeutic product candidates in clinical development. The Company’s current products include the Helix™ transendocardial delivery system, the Morph® steerable guide and sheath catheter portfolio and the AVANCE™ steerable introducer family. BioCardia also partners with other biotherapeutic companies to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction.

Forward Looking Statements 
This press release contains forward-looking statements that are subject to many risks and uncertainties. In particular, the outcome and timing of litigation are uncertain.  These forward-looking statements are made as of the date of this press release, and BioCardia assumes no obligation to update the forward-looking statements.

Announcements

View All
Announcements Consumer

Legal-Bay Lawsuit Funding Announces Commercial Litigation/Breach of Contract Lawsuit Filed Against Developer Hart Lyman Companies

By Harry Moran |

Legal-Bay, a leading presettlement lawsuit funding company, announces a commercial litigation / breach of contract lawsuit filed against Hart Lyman Companies. The prominent Syracuse-based real estate developer was sued late Tuesday in New York State Supreme Court, Onondaga County. FILED: ONONDAGA COUNTY CLERK 01/07/2025 05:48 PM INDEX NO. 000134/2025

The plaintiff, Jonathon Geller, a longtime investor with Hart Lyman Companies, is suing for delinquent payments on investments and inspection of books and records of eight separate entities, which he alleges the companies have not complied with. Hart Lyman Companies is currently working on the largest development in central New York history, the Great Northern Mall, whose purchase was predicated upon its close proximity to the future site of Micron Technologies. Micron has committed $100 billion toward developing multiple chip fabricating facilities in Clay, NY. The plaintiff is also an investor in the Great Northern Mall project.

The plaintiff is represented by the LAZARE POTTER GIACOVAS & MOYLE LLP law firm in New York City by Robert A. Giacovas, Esq.

Chris Janish, CEO of Legal-Bay, commented, "Our firm is familiar with breach of contract and other commercial litigation such as this, and we do our best to work with plaintiffs who are having financial difficulties litigating matters against larger defendants.  Cases of this nature can take a long time to work their way through the courts and recover funds, regardless of the nature of the claims.  Due to the importance of the Great Northern Mall project for residents of central New York, we will continue to monitor updates of this case."

If you're looking for pre-settlement cash from your commercial litigation lawsuit or need a cash advance from your anticipated settlement for any other type of lawsuit, please visit the company's website HERE or call 877.571.0405 where agents are standing by to hear about your specific case. 

Legal-Bay funds commercial litigation and breach of contract cases, as well as many other types of lawsuits such as wrongful imprisonment, whistleblower or Qui-Tam, wrongful termination, personal injury, slips and falls, car, boat, or construction accidents, medical malpractice, wrongful death, dog bites, police brutality, sexual assault, sexual abuse, judgment or verdict on appeal, contract dispute, False Claims Act, patent litigation, copyright infringement, and many more. Legal-Bay has recently secured additional capital for these and other types of cases, and encourages plaintiffs or attorneys that have been denied funding in the past to apply with Legal-Bay.

Legal-Bay's loan for settlement funding programs are designed to provide immediate cash in advance of a plaintiff's anticipated monetary award. While it's common to refer to these legal funding requests as settlement loans, loans for settlements, lawsuit loans, loans for lawsuits, etc., the "lawsuit loan" funds are, in fact, non-recourse. That means there's no risk when it comes to loans in lawsuit settlements because there is no obligation to repay the money if the recipient loses their case. Therefore, terms like settlement loan, loans for lawsuit, loans on settlement, or law suit loan funds don't necessarily apply, as the "loan on lawsuit" isn't really a loan at all, but rather a stress-free cash advance.

Legal-Bay is known to many as the best lawsuit funding provider in the industry for their helpful and knowledgeable staff, and one of the best lawsuit loan companies overall for their low rates and quick turnaround, sometimes within 24-48 hours once all documents have been received.To apply right now for a loan settlement program, please visit the company's website HERE or call toll-free at: 877.571.0405 where agents are standing by to answer any questions.

Announcements Commercial People Moves

Exton Advisors Appoints Senior Finance Professional Timothy Mayer

By Harry Moran |

Leading global advisors in disputes finance, Exton Advisors, today announces the appointment of experienced funder and lawyer Timothy Mayer to its team, marking the start of an exciting year for the firm.

Called to the Bar in 1997, Timothy has over sixteen years’ experience in the disputes funding market, having spent time at some of the leading global dispute’s funders. He has managed multi-million investments across a broad range of disputes, with particular focus on international arbitration, and has been consistently recognised in the directories, including as a Global Leader in Legal Finance in the Law Dragon Global 100 guide (2020 – 2023) and Chambers and Partners Litigation Support Guide for Litigation Funding (2020 -2024).

Commenting on the appointment, Managing Director John Astill said, “We are delighted to welcome Timothy, and to grow our team in 2025. Timothy brings with him a unique combination of practical legal experience and disputes finance expertise that will be invaluable to our clients and will further strengthen the seamless and efficient approach to disputes finance that Exton Advisors offers.”

Timothy commented, “I am thrilled to join Exton Advisors at an exciting time for the business, and I look forward to the opportunity to be part of a truly unique service spanning the legal and funding spheres. No other disputes funding advisory exists quite like Exton Advisors, and I am keen to continue developing their distinctive approach to disputes financing.”

Exton Advisors deliver expertise in every aspect of the unique and complex disputes financing asset class. They advise corporate legal teams, their private practitioners and their funding partners in order to make the most of litigation assets.

About Exton Advisors

Exton Advisors deliver expertise in every aspect of the unique and complex litigation financing asset class. They advise corporate legal teams, their private practitioners and their funding partners in order to make the most of litigation assets.

Announcements Consumer

Tribeca Lawsuit Loans To Provide Legal Funding To Transferred FCI Dublin Prisoners

By John Freund |

Two lawyers, Susan Beaty and Kara Janssen, have been actively advocating for the women of FCI Dublin and have uncovered alarming reports of sexual harassment and assault. The incarcerated women have since been relocated to various federal prisons across the country, including a facility in Aliceville, Alabama.

Tribeca Lawsuit Loans provides pre-settlement funding to empower the FCI Dublin victims to pursue justice during this difficult time.

Abuse Persists After FCI Dublin's Closure

Earlier this year, the FCI Dublin was shut down due to the pervasive sex abuse scandal involving prison staff. As a result, the women incarcerated were relocated to different federal prisons nationwide, including Aliceville in Alabama. Instead of finding relief and rehabilitation, more reports of abuse and retaliation have emerged for speaking out against the past misconduct that occurred in Dublin.

According to Beaty and Janssen, multiple women relocated to FCI Aliceville experienced harassment because of their affiliation with the Dublin scandal. Additionally, several women came out claiming that they were sexually assaulted by the guards at Aliceville.

These series of abuses and their nature deeply ingrained within the system highlights the flaws within the Bureau of Prisons (BOP). Although the BOP has conducted investigations and mass interviews, this did little to give security and restore trust among incarcerated women. Reports of poor confinement conditions and lack of access to mental health services only make it harder for these women to deal with the trauma.

Tribeca's Commitment to Human Rights

Tribeca Lawsuit Loans is deeply committed to respect for human rights, including the right to safety and dignity even in correctional facilities. Understanding the need for justice in these circumstances, Tribeca introduces its initiatives to provide lawsuit loans for the victims of abuse at FCI Dublin and other federal prisons.

Legal battles against large institutions like the BOP can be a huge undertaking and could require significant resources. Most of the victims and their families don't have the financial means to pursue their cases, especially in instances of mistreatment and abuse.

Tribeca Lawsuit Loans aims to empower the victims by aiding them financially to secure skilled legal representation and cover necessary expenses without upfront costs.

Tribeca Lawsuit Loans to Provide Legal Funding for Prison Abuse Victims

Tribeca Lawsuit Loans extends financial assistance to prisoners at FCI Aliceville and other related facilities through lawsuit cash advances, also known as pre-settlement loans, based on the class action lawsuit filed against the Bureau of Prisons. This legal action addresses the allegations of misconduct and abuse within federal prisons, emphasizing cases of sexual abuse involving prison staff.

Tribeca's dedication extends beyond financial support. It is a catalyst for systemic change within the federal prison. By collaborating with victims, lawyers and advocacy groups, Tribeca hopes to bring these injustices to the forefront and hold the responsible parties accountable.

If you or someone close to you require financial support in the middle of an ongoing case, don't hesitate to reach out. Call us now at (866) 388-2288 or apply online via our secure online form.

ABOUT US: TRIBECA Capital Group is a litigation finance company funding those across the nation involved in lawsuits, and need an upper hand financially to level the playing field.